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Abstract
Background: Renal injury is a serious complication after cardiac surgery and therefore, early detection and much
more prediction of postoperative kidney injury is desirable. Neutrophil gelatinase-associated lipocalin (NGAL) is a
predictive biomarker of acute kidney injury and may increase after cardiopulmonary bypass (CPB). However, time
correlation of NGAL expression and severity of renal injury is still unclear. The aim of our study was to investigate
CPB-related urine NGAL (uNGAL) secretion in correlation to postoperative renal function.
Methods: Data of NGAL expression along with clinical data of 81 patients (52 male and 29 female) were
included in this study. Mean age of the patients was 66.8 ± 12.8 years. Urine NGAL was measured at seven
time points (T0: baseline; T1: start CPB, T2: 40 min on CPB; T3: 80 min on CPB; T4: 120 min on CPB; Tp1: 15 min after CPB;
Tp2: 4 h after admission to the intensive care unit) and renal function in the postoperative period was classified daily
according to Acute Kidney Injury Network (Ronco et al, Int J Artif Organs 30(5): 373–6) criteria (AKIN).
Results: Expression of uNGAL increased at T4 (120 min on CPB) and post-CPB (Tp1 and Tp2; p < 0.01 vs. baseline) but
there was no correlation between uNGAL level and duration of CPB nor between uNGAL expression and occurrence of
postoperative kidney injury. The renal function over 10 days after surgery remained normal in 50 patients (AKIN level 0),
18 patients (22%) developed mild and insignificant renal injury (AKIN level 1), eight patients (10%) developed moderate
renal failure (AKIN level 2), and five patients (6%) severe kidney failure (AKIN level 3). Twenty-four out of 31 patients
developed renal failure within the first 48 h after surgery. However, there was no correlation between uNGAL
expression and severity of acute renal failure.
Conclusion: Although uNGAL expression increased after CPB, the peak values neither predict acute postoperative
kidney injury, nor severity of the injury.
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Background
Renal injury after cardiac surgery is a common compli-
cation with significant consequences, regarding progno-
sis of the patient, intensive care unit stay and therapy
costs. The aetiology seems to be multifactorial: low renal
blood flow during cardiopulmonary bypass (CPB) may
trigger renal failure; several proinflammatory mediators,
such as interleukins, TNFα and other metabolites can
lead to membrane damage of the renal tubular epithe-
lium [1–6]. The evaluation of renal function is still based
on creatinine serum levels, which is simple and less ex-
pensive but also with delayed information about acute
changes of renal function [7, 8]. The early prediction of
the occurrence of acute kidney injury (AKI) after cardiac
procedures is of essential importance, as this could re-
strict further kidney damage and thus improve patient
outcome.
Neutrophil gelatinase-associated lipocalin in urine
(uNGAL) has been tested as a predictive biomarker of
AKI in both experimental and clinical studies [1, 3, 6–8].
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In a renal ischemia-reperfusion injury model in the
mouse and rat, a marked upregulation of NGAL mRNA
and protein levels was seen in the early postischemic
period, whereas the appearance of uNGAL in the very
first postischemic urine output was related to the dur-
ation of ischemia [9]. Woodson et al. found in the rat
model increased expression of uNGAL after 30 min of
kidney hilum clamping then after 15 and 60 min [10].
Clinical studies of cardiac surgery showed in patients
with postoperative AKI increased uNGAL values 2 to
4 h after CPB [1, 6, 7, 11–13]. In most studies, measure-
ments of uNGAL were carried out preoperatively (base-
line value), and once again postoperatively at admission
of the patients in the intensive care unit (ICU). There
are no data of uNGAL during CPB available. The aim of
the present study was (1) the measurement of uNGAL
expression even during on-pump cardiac surgery, (2) the
relationship analysis between uNGAL values and clinical
renal outcome, and (3) the analysis of the predictive
power of uNGAL on the severity of postoperative AKI.
Methods
Eighty-one adult patients undergoing cardiac surgery
with the use of CPB were included: 34 patients coronary
artery bypass grafting (CABG), 19 patients with valve re-
placements, 22 patients combined CABG and valve re-
placement, 2 patients with myectomy of hypertrophic
cardiomyopathy, 2 patients with aortic reconstruction,
and 1 patient with closure of atrial septum defect.
Exclusion criteria were: terminal renal insufficiency, ir-
regular kidney vessels, abnormal kidney morphology
(confirmed by ultrasound or magnetic resonance im-
aging) or preoperative haemodynamic instability.
The preoperative ARF (acute renal failure) score
(includes the following 11 preoperative variables: gen-
der, congestive heart failure, left ventricular ejection frac-
tion, use of intra-aortic balloon counterpulsation, chronic
lung disease, insulin-requiring diabetes mellitus, previous
cardiac surgery, emergency surgery, valve surgery, proce-
dures other than coronary bypass or valve and serum cre-
atinine) was calculated [14].
Urine samples for biomarker analysis were obtained
immediately before (T0: baseline, before induction of
anesthesia), during CPB (T1: start CPB; T2: 40 min on
CPB, T3: 80 min on CPB; T4: 120 min on CPB) and after
CPB (TP1: 15 min after CPB; TP2: 4 h after admission
into ICU (over 5 h after CPB).
The samples were centrifugated and stored in aliquots at
−80 °C. The quantitative assessment of uNGAL was per-
formed with the ARCHITECT platform (Chemilumines-
zenz-Micropartikelimmunoassay (CMIA), Abott GmbH &
Co. KG, Wiesbaden, Germany).
Serum creatinine and glomerular filtration rate (eGFR)
were routinely measured at baseline (within 72 h before
surgery), after admission to the ICU and at least daily in
the post-operative period up to 15 days.
The severity of postoperative acute kidney injury was
defined and stratified according to the Acute Kidney In-
jury Network criteria [11, 15]:
 AKIN level 0: no changes
 AKIN level 1: increased serum creatinine for 1.5–2x
of the basal value or increased serum creatinine ≥
0,3 mg/dl or > 25%, reduction of GFR / Urine
output < 0.5 mL/kg/h > 6 h
 AKIN level 2: increased serum creatinine for 2–3 of
basal value or >50% reduction of GFR / Urine
output < 0.5 mL/kg/h > 12 h
 AKIN level 3: increased serum creatinine for > 3 of
basal value or >75% reduction of GFR or ein serum
creatinine ≥ 4 mg/dl / Urine output < 0.3 mL/kg/h >
24 h or anuria for 12 h
All patients were classified according to these criteria.
Since creatinine levels and diuresis over the past 6 h,
12 h , or 24 h is included in calculation of AKIN levels,
levels were determined every day postoperatively.
In general, patients with AKIN level 0 or level 1 re-
ceived no specific therapy, whereas therapy was modified
for patients with AKIN level 2 and level 3 (differentiated
volume substitution therapy, diuretics or renal replace-
ment therapy).
All statistical analyses were performed using statistical
software SAS (version 9.3, SAS Institute Inc., Cary, NC,
USA) or STATISTICA (version 9.1, StatSoft Inc., USA).
Continuous variables were described as means (with
standard deviation) or medians (with inter-quartile range),
as appropriate, and categorical variables as percentages.
The Wilcoxon rank sum test was used to compare urinary
biomarker levels at each time point between patients with
and without AKI. For statistical analysis of possible effect
of the factor AKIN level and time or interaction of both
factors with the NGAL concentration and NGAL
amounts, a nonparametric two-factorial ANOVA with
interaction term was performed . The significance level
and the P values were adjusted using the Bonferroni-
Holm method. Differences were considered statistically
significant at a P value of less than 0.05.
Results
Eighty one patients, 29 women (mean age 68 ± 9 years)
and 52 men (mean age 67 ± 14) were included in the
study. Coronary artery bypass grafting (GABG) was per-
formed in 35 patients (16 female, 19 male), valve re-
placement in 19 patients (6 female, 13 male), and
combined procedures in 27 patients (7 female, 20 male).
The concentration of uNGAL, decreased significantly
at the beginning of CPB (T1) (p < 0.01 vs. T0) without
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further significant changes until 80 min on CPB (T3). At
120 min on CPB and thereafter uNGAL increased sig-
nificantly (p < 0.01 vs. T0) (Fig. 1).
Up to 10 days after surgery fifty patients (62%) had a
normal renal outcome (AKIN level 0), 18 patients (22%)
were in AKIN level 1, eight patients (10%) developed
AKIN level 2, and five patients (6%) developed severe
renal injury (AKIN level 3). Four patients of five in AKIN
level 3 underwent hemodialysis. Most patients, 27 out of
31, developed the renal injury (AKIN level 1, 2, and 3)
within the first four postoperative days. The clinical data
of the patients did not show significant differences
(Table 1). Nine additional patients (11%) developed renal
failure after the 4th postoperative day (Fig. 2). Three
patients died postoperatively; one patient without and two
patients with severe postoperative renal injury.
No significant differences in patient characteristics
were noted between the groups with renal injury (AKIN
levels 2 and 3) if compared to patients at AKIN level 0
and 1 (Table 2). The preoperative ARF-score was notably
higher in patients who later developed kidney damage as
in patients without severe renal injury (Table 3).
The relation of maximal uNGAL values (at Tp2) and
developed postoperative AKIN levels does not show
significant correlation for prediction (Fig. 3). Also the
relation of uNGAL values (at Tp1 and Tp2) to dur-
ation of CPB does not show significant correlation
(Fig. 4).
Fig. 1 The median uNGAL concentrations of all study patients at the different measurement points. T0: baseline; T1: start CPB (n = 81); T2: 40 min
CPB (n = 81); T3: 80 min CPB (n = 70); T4: 120 min CPB (n = 40); TP1: 15 min after CPB (n = 81); TP2: 4 h after admission to the intensive care unit (n
= 81). *p < 0.01 if compared to T0
Table 1 Preoperative, operative, and postoperative clinical data of the patients after on-pump cardiac surgery according to AKIN
levels on postoperative day 4
AKIN level 0 AKIN level 1 AKIN level 2 AKIN level 3
Males/Females 30/15 15/6 5/3 2/5
Age (years) 62.9 ± 14.1 72.5 ± 9.3 70.5 ± 4.4 74.9 ± 3.3
Weight [16] 79.9 ± 16.2 80.9 ± 15.8 93.0 ± 25.6 83.8 ± 13.7
CPB duration (minutes) 139.3 ± 50.2 148.1 ± 50,8 152.9 ± 59.7 130.3 ± 30.9
Stay in OR (minutes) 249.7 ± 71.6 248.6 ± 73.4 267.3 ± 78.6 241.9 ± 28.9
Intraoperative urine output (ml/kg) 10.4 ± 15.8 7.2 ± 6.7 4.9 ± 3.8 18.3 ± 36.6
Early postoperative urine output (5 h) (ml/kg) 8.7 ± 4.7 7.4 ± 5.0 5.2 ± 4.8 5.7 ± 3.5
Peak free Hb in blood (mg/100 mL) 57.6 ± 29.0 59.3 ± 20.1 71.3 ± 23.2 62.5 ± 31.1
Peak free Hb in urine (mg/100 mL) 22.2 ± 38.3 13.8 ± 12.1 20.0 ± 16.9 34.0 ± 61.0
ICU stay (days) 2.5 ± 2.3 4.9 ± 6.3 4.3 ± 3.0 6.4 ± 3.8
CPB cardiopulmonary bypass, OR operating room, Hb hemoglobin, ICU intensive care unit
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Also in subgroup analysis (CABG, valve replacement,
combined procedure, or other) there was no significant
correlation between uNGAL value and AKIN level.
Discussion
Acute kidney injury after cardiac surgery is a common
complication and outcome may be devastating with a
mortality-risk of up to 90% [6, 11, 16–19]. According to
AKIN classification, changes in serum creatinine concen-
trations and reduced urine output define acute kidney in-
jury. Therefore, changes of kidney function are detected
with substantial delay. Changes of diuresis and/or serum
creatinine levels that appear in the postoperative period
can be directly ascribed to CPB, but also to various
factors, as haemolysis, blood transfusions, volume deficit,
haemodynamic instability, systemic inflammatory re-
sponse (SIRS), or reduction of renal perfusion in the
elderly [15, 20]. Nevertheless, early prediction of the oc-
currence of AKI after surgery is of crucial importance.
NGAL is a multi-potent 25-kDa protein mainly se-
creted by neutrophils, playing a fundamental role in iron
metabolism [21, 22]. Although the dimeric NGAL is also
expressed by other organs [23], the monomeric form is
expressed by urothelial cells of the renal tubular system
and has been specifically associated with epithelial stress
[24, 25]. It is excreted in great amounts in urine [26]
and in cases of ‘tubular stress’ it appears relatively early
(60–120 min after stress induction) in the primary urine
[27–29]. Although NGAL is an early predictive bio-
marker of acute kidney injury (AKI) some limitations of
the certainty of NGAL’s predictive feature have been re-
ported [6, 11, 12].
In general, the value of the costly analysis of several
predictive biomarkers, such as uNGAL, interleukin-18
(IL-18), kidney injury molecule (KIM-1), N-acetyl-beta-
D-glucosaminidase (NAG) and others, in comparison to
the daily routine creatinine measurement is increasingly
doubted. The aim of our study was to evaluate the use
of uNGAL as a biomarker of AKI after cardiac surgery
with CPB, assessing its concentration levels at seven cru-
cial time points, i.e. before, during and after extracorpor-
eal circulation. Additionally, we wanted to analyze the
predictive power of uNGAL on severity of AKI. To the
best of our knowledge, this is the first study which
covers extensively the concentration fluctuations of
uNGAL on pump in cardiac surgery.
If renal injury during extracorporeal circulation were
caused by reduced renal perfusion, then an increase in
NGAL-expression would be already expected in the in-
traoperative period. Our measurements showed a signifi-
cant decrease of uNGAL at the beginning of
cardiopulmonary bypass, whereas a significant increase
of uNGAL was seen after 120 min of CPB. The initial
Fig. 2 Number of patients in the corresponding AKIN groups over 10 days after surgery
Table 2 Clinical data of the patients after CPB surgery classified
to AKIN levels on postoperative day 4. Patients in AKIN level 0 +
1 did not receive specific renal treatment
AKIN level 0 + 1 AKIN level 2 + 3 p-value
Patients 66 15
Male gender (%) 45 (55.6) 7 (8.6) 0.117
Age (years) 66 (21–87) 73 (62–79) 0.071
Weight (kg) 80 89 0.087





urine output (5 h; (ml/kg)
8.0 5.5 0.094
ICU stay (days) 3.2 5.3 0.063
Hospital stay (days) 13.5 14.7 0.637
CPB cardiopulmonary bypass, ICU intensive care unit
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uNGAL decrease is probably caused by haemodilution at
the induction of anaesthesia. After 2 h on CPB and at
the end of surgery and afterwards significant increase of
uNGAL was seen. However, a statistical difference in
uNGAL concentration was only observed between AKIN
level 0 and AKIN level 1 (p < 0.05), so in patients with-
out clinically relevant kidney injury. All other compari-
sons, i.e. between AKIN level 0 and AKIN level 2 or
AKIN level 1 and AKIN level 2 did not demonstrate any
statistical significant difference (p = 0.328 and p = 0.916,
respectively).
Arteriosclerosis is a generalised disease which may
affect many vessels and therefore CABG patients
may have a higher risk for end organ failure based
on the underlying disease. Although we would ex-
pect more kidney injury in CABG patients, we did
not find significant differences between the proced-
ure subgroups.
A limitation exists with sustained diuresis, as no de-
termination of uNGAL concentrations can be made.
The problem that arises is the possibility of miscalcu-
lations and misinterpretation of invalid results. Meas-
uring uNGAL (ng/ml) in differential urine volumes by
anuric and/or polyuric phases is less representative of
the filtration and concentration efficacy of the kidneys
as quantitatively measuring uNGAL per time interval
(μg/min). Therefore, we have also compared the
uNGAL concentrations to the uNGAL quantity per
sample collection intervals and no differences were
found.
Since NGAL participates in iron metabolism, free haemo-
globin (Hb) in plasma and urine was measured but there
Table 3 The preoperative values of the calculated Acute Renal Failure (ARF) scores, the creatinine, and the estimated glomerular
filtration rate (GFR) in relation to the AKIN-levels classified on postoperative day 4. The calculated ARF score in AKIN-levels 2 + 3 were
significantly higher than in AKIN-levels 0 + 1 (4.07 ± 2.46 vs. 2.91 ± 1.83, p = 0.043)
AKIN 0 AKIN 1 AKIN 2 AKIN 3
ARF score 2.62 ± 1.74 3.52 ± 1.84 3.75 ± 1.85 4.43 ± 1.82
2.91 ± 1.83 4.07 ± 2.46
Creatinine (mg/dl) 0.99 ± 0.53 1.11 ± 0.33 1.03 ± 0.32 1.32 ± 0.64
1.03 ± 0.48 1.17 ± 0.53
GFR (ml/min/1.73 m2) 91.6 ± 41.9 69.8 ± 23.7 89.8 ± 34.7 43.3 ± 23.2
83.3 ± 33.82 68.1 ± 26,83
Fig. 3 Correlation of uNGAL concentrations to corresponding AKIN levels on postoperative days 2, 4, 6, 8, and 10. The scatter-plots show uNGAL
values at Tp1 and Tp2. A good prognostic valence is given if the values were mostly in the left upper half of the diagram (shadow area of index
chart “expected range”)
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was no correlation between the highest uNGAL concentra-
tions, the peak free-Hb values, and the postoperative AKIN
level (Table 1).
The onset of the renal injury during and after CPB is
very difficult to be determined, even with the help of
modern biomarkers. As several studies, also present
study failed to demonstrate a correlation between peak
uNGAL value, duration of CPB, and the occurrence of
AKI [6, 11, 29–31]. The mean CPB duration in all our
patients was 141 min; in the group of patients, who de-
veloped severe kidney injury (AKIN level 3), the mean
CPB time was 130 min (Table 3). Moreover, a compari-
son of CPB duration between the groups of patients
without postoperative essential renal injury (AKIN level
0, AKIN level 1) and with renal injury (AKIN level 2,
AKIN level 3) revealed no significant difference (CPB
time 141.7 min in AKIN 0/1 groups vs. 141.3 min in
AKIN 2/3, p = 0.966).
In our study, increased uNGAL concentration was not
a certain predictor of the degree of an upcoming renal
injury. We expected to find good prediction of AKI
within the first 4 days after CPB but there was for any
time after CPB no correlation between uNGAL and
postoperative AKIN classification level.
Conclusion
The results of present study clearly demonstrate that the
biomarker uNGAL failed to predict the onset and the se-
verity of acute renal failure after cardiac operations with
extracorporeal circulation. Further studies are needed to
analyze possible markers predicting postoperative kidney
injury.
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